跳至主要内容
临床试验/NCT04047745
NCT04047745Unknown不适用

The Use of Liposomal Bupivacaine Interscalene Brachial Plexus Block for Rotator Cuff Surgery: A Randomized, Double Blind, Clinical Trial

Rothman Institute Orthopaedics1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2019年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
132
试验地点
1
主要终点
opioid consumption

研究概览

简要总结

The primary purpose of this study is to determine if the postoperative oral narcotics consumption in patients receiving liposomal bupivacaine (LB) interscalene brachial plexus nerve block (ISBPB) is different than the narcotics consumption receiving traditional bupivacaine ISBPB for arthroscopic rotator cuff repair analgesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged 18 years or older with a full-thickness rotator cuff tear (confirmed on MRI) undergoing arthroscopic rotator cuff repair surgery.
  • Anesthesiologists physical status 1, 2, or 3 and normal preoperative motor (Lovett scale: biceps, wrist, thumb) and sensory function.

排除标准

  • Revision shoulder surgery
  • History of more than 1 prior surgery performed on the operative shoulder
  • Concomitant severe glenohumeral arthritis
  • Concomitant adhesive capsulitis
  • Worker's compensation claim
  • Pregnancy
  • History of hypersensitivity or idiosyncratic reaction to amide-type local anesthetics
  • History of renal or hepatic failure
  • Chronic neuromuscular deficit affecting the surgical limb.
  • Uncontrolled psychiatric or neurologic disorder

研究组 & 干预措施

liposomal bupivacaine

Active Comparator

干预措施: Liposomal bupivacaine (Drug)

ropivacaine

Active Comparator

干预措施: Ropivacaine injection (Drug)

结局指标

主要结局

opioid consumption

时间窗: surgery through 48 hours post-op

postsurgical opioid consumption

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Post-operative Exparel Study Following Rotator Cuff... | 临床试验